These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29097274)

  • 1. Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients.
    Chan A; Yo TE; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    J Pain Symptom Manage; 2018 Mar; 55(3):992-997.e2. PubMed ID: 29097274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.
    Cheung YT; Foo YL; Shwe M; Tan YP; Fan G; Yong WS; Madhukumar P; Ooi WS; Chay WY; Dent RA; Ang SF; Lo SK; Yap YS; Ng R; Chan A
    J Clin Epidemiol; 2014 Jul; 67(7):811-20. PubMed ID: 24656406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimal clinically important difference of two multifaceted fatigue evaluation questionnaires in chronic stroke.
    Fallah S; Parnain Z; Taghavi-Azar-Sharabiani P; Cheraghifard M; Vasaghi-Gharamaleki B; Roohi-Azizi M; Hashemi M; Yousefi M; Joghataei MT; Taghizadeh G
    Top Stroke Rehabil; 2024 Oct; ():1-14. PubMed ID: 39356733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
    Ogura K; Yakoub MA; Christ AB; Fujiwara T; Nikolic Z; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2020 Sep; 478(9):2148-2158. PubMed ID: 32568896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Short Form Health Survey Score Is Predictive of Return to Play and Minimal Clinically Important Difference at a Minimum 2-Year Follow-up After Anterior Cruciate Ligament Reconstruction.
    Nwachukwu BU; Chang B; Voleti PB; Berkanish P; Cohn MR; Altchek DW; Allen AA; Williams RJ
    Am J Sports Med; 2017 Oct; 45(12):2784-2790. PubMed ID: 28727937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.
    Yeo F; Ng CC; Loh KWJ; Molassiotis A; Cheng HL; Au JSK; Leung KT; Li YC; Wong KH; Suen L; Chan CW; Yorke J; Farrell C; Bandla A; Ang E; Lopez V; Sundar R; Chan A
    Support Care Cancer; 2019 Dec; 27(12):4753-4762. PubMed ID: 30972646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal clinically important difference in the treadmill six-minute walk test in active women with breast cancer during and after oncological treatments.
    Cantarero-Villanueva I; Postigo-Martin P; Granger CL; Waterland J; Galiano-Castillo N; Denehy L
    Disabil Rehabil; 2023 Mar; 45(5):871-878. PubMed ID: 35352996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of the multidimensional fatigue symptom inventory-short form.
    Donovan KA; Stein KD; Lee M; Leach CR; Ilozumba O; Jacobsen PB
    Support Care Cancer; 2015 Jan; 23(1):191-212. PubMed ID: 25142703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further validation of the multidimensional fatigue symptom inventory-short form.
    Stein KD; Jacobsen PB; Blanchard CM; Thors C
    J Pain Symptom Manage; 2004 Jan; 27(1):14-23. PubMed ID: 14711465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial.
    Zhang LL; Wang SZ; Chen HL; Yuan AZ
    J Pain Symptom Manage; 2016 Mar; 51(3):504-11. PubMed ID: 26721747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persian version of the Chalder Fatigue Questionnaire and Multidimensional Fatigue Symptom Inventory-Short Form: psychometric properties in Iranian chronic stroke survivors.
    Fallah S; Taghizadeh G; Parnain Z; Cheraghifard M; Taghavi Azar Sharabiani P; Yousefi M; Joghataei MT; Gholizade A
    Top Stroke Rehabil; 2023 Dec; 30(8):796-806. PubMed ID: 37723098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
    Zeng L; Chow E; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bedard G; Bottomley A
    Support Care Cancer; 2012 Dec; 20(12):3307-13. PubMed ID: 22562607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of a Chinese version of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF-C).
    Pien LC; Chu H; Chen WC; Chang YS; Liao YM; Chen CH; Chou KR
    J Clin Nurs; 2011 Aug; 20(15-16):2224-32. PubMed ID: 21615574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.
    Hui D; Shamieh O; Paiva CE; Khamash O; Perez-Cruz PE; Kwon JH; Muckaden MA; Park M; Arthur J; Bruera E
    J Pain Symptom Manage; 2016 Feb; 51(2):262-9. PubMed ID: 26482223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the multidimensional fatigue symptom inventory-short form in an African-American community-based sample.
    Asvat Y; Malcarne VL; Sadler GR; Jacobsen PB
    Ethn Health; 2014; 19(6):631-44. PubMed ID: 24527980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
    Wong E; Zhang L; Kerba M; Arnalot PF; Danielson B; Tsao M; Bedard G; Thavarajah N; Cheon P; Danjoux C; Pulenzas N; Chow E
    Support Care Cancer; 2015 Sep; 23(9):2731-7. PubMed ID: 25663577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective Study.
    Baughman RP; Judson MA; Beaumont JL; Maier LA; Sweiss NJ; Culver DA; Chen ES; Singh N; Lower EE; Reeves R; Hamzeh N; Grutters JC; Valeyre D; Birring SS
    Ann Am Thorac Soc; 2021 Mar; 18(3):477-485. PubMed ID: 32970455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.